Eye melanoma
Advancing the care of patients with uveal melanoma
HeroChildModel(linkUtils=au.edu.sydney.commons.core.utils.LinkUtils@89df813, ctaUrl=https://www.sydney.edu.au/save-sight-institute/patient-services.html, ctaDescription=Patient services, arialabel=),HeroChildModel(linkUtils=au.edu.sydney.commons.core.utils.LinkUtils@89df813, ctaUrl=https://www.sydney.edu.au/save-sight-institute/support-us.html, ctaDescription=Support us, arialabel=)
Our Ocular Oncology Group is dedicated to advancing the care of patients with uveal melanoma, the most common primary intraocular cancer in adults.
Our work spans laboratory-based investigations of tumour biology and immune interactions, to innovations in localised therapies that preserve vision, and systemic treatments to reduce mortality.
Our supporters and collaborators include the Sydney Eye Hospital Foundation, Save Sight Institute Registries (Fight Tumour Blindness!), NHMRC, the Melanoma Institute of Australia and global cancer research networks.
Email
Submit your enquiry
Mailing address
South Block, Sydney Eye Hospital
8 Macquarie Street
Sydney, NSW 2000